Jasper Therapeutics (JSPR) Non-Current Assets (2019 - 2026)
Jasper Therapeutics (JSPR) recorded Non-Current Assets of $231,000 in Q2 2026, down 93.4% from $3.5 million a year earlier.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Jasper Therapeutics reported Non-Current Assets of $1.13 million, down 72.3% from FY2024.
- Annual Non-Current Assets has declined for three straight years, with a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $4.09 million in FY2024 (-31.3%), $5.95 million in FY2023 (-10.2%), $6.63 million in FY2022 (+13.9%) and $5.82 million in FY2021 (+117.9%).
- The Q2 2026 figure is the lowest quarterly Non-Current Assets in data going back to Q4 2019.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 117.9% in Q4 2021, against a decline of 95.2% in Q3 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.41 Bn | 1,108.99 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 618.57 Bn | 537.10 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 509.95 Bn | 483.06 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.63 Bn | 321.01 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.47 Bn | 262.46 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 263.21 Bn | 236.89 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.71 Bn | 192.11 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 193.05 Bn | 167.25 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Jasper Therapeutics | 14.69 Mn | -111.73 Mn | - | 231,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231,000.00 |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 2.91 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 5.25 Mn |
| Mar 31, 2024 | 5.66 Mn |
| Dec 31, 2023 | 5.95 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 5.60 Mn |
| Mar 31, 2023 | 6.25 Mn |
| Dec 31, 2022 | 6.63 Mn |
| Sep 30, 2022 | 6.70 Mn |
| Jun 30, 2022 | 7.08 Mn |
| Mar 31, 2022 | 6.75 Mn |
| Dec 31, 2021 | 5.82 Mn |
| Sep 30, 2021 | 4.81 Mn |
| Jun 30, 2021 | 100.13 Mn |
API Access
Jasper Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();